ArticleNature reviews. Clinical oncology2018
Eliminating MRD - FDA approval of blinatumomab for B-ALL in complete remission.
Talal Hilal et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papertrialcites it
ArticleNature reviews. Clinical oncology2018
Talal Hilal et al.PubMed ↗Publisher ↗
No numbers read from the abstract.